In a non‑smoking adult with chronic worsening cough and CT chest showing small mediastinal lymph nodes (≤0.8 cm), subpleural scarring, mild interstitial changes in the right middle lobe and lingula, and bronchiolectasis with mild bronchial wall thickening in the lower lobes, what diagnostic work‑up and management plan is recommended?

Diagnostic Work-Up and Management for Chronic Cough with CT Findings

This patient requires further diagnostic evaluation with pulmonary function testing, sputum culture, and consideration of bronchoscopy with bronchoalveolar lavage, as the CT findings of bronchiolectasis and interstitial changes suggest underlying bronchiectasis or early interstitial lung disease that warrants specific characterization and treatment.

Initial Diagnostic Approach

Confirm Bronchiectasis Diagnosis

• The CT findings of bronchiolectasis and bronchial wall thickening in the lower lobes meet radiographic criteria for bronchiectasis (bronchoarterial ratio >1, lack of tapering, or airway visibility within 1 cm of pleural surface) 1
• Bronchiectasis is a clinically relevant finding that requires confirmation during stable disease and warrants investigation for underlying etiology 1
• The presence of mediastinal lymph nodes up to 0.8 cm is commonly seen in bronchiectasis as reactive lymphadenopathy (detected in 81% of bronchiectasis patients, with nodes >10 mm in 29%) 2

Evaluate for Interstitial Lung Disease

• The mild interstitial prominence in the right middle lobe and lingula, combined with subpleural scarring, raises concern for early interstitial lung abnormalities (ILAs) 1
• While the extent appears limited (<5% lung volume), the presence of traction bronchiolectasis is a key feature suggesting fibrotic changes 1
• The combination of interstitial changes and bronchiolectasis can represent either bronchiectasis with secondary interstitial changes or early ILD with traction bronchiectasis 1

Essential Diagnostic Tests

Pulmonary Function Testing

• Obtain complete spirometry with lung volumes and diffusion capacity (DLCO) to assess for obstructive pattern (bronchiectasis) versus restrictive pattern (ILD) 3
• Bronchoprovocation testing should be considered if baseline PFTs are normal to exclude cough-variant asthma or post-viral bronchitis 3

Microbiological Evaluation

• Obtain sputum culture for potentially pathogenic microorganisms, including Pseudomonas aeruginosa, as chronic infection is common in bronchiectasis 1
• Persistent mucopurulent or purulent sputum production is an indication for bronchiectasis investigation 1

Additional Laboratory Work-Up

• Screen for underlying causes of bronchiectasis: immunoglobulin levels, alpha-1 antitrypsin, rheumatoid factor, and ANCA if clinically indicated 1
• Consider autoimmune serologies (ANA, RF, anti-CCP) given the interstitial changes and potential for connective tissue disease-associated ILD 1

Advanced Diagnostic Considerations

Bronchoscopy Indications

• Consider bronchoscopy with bronchoalveolar lavage if:
  • Interstitial changes progress on follow-up imaging 1
  • PFTs show restrictive physiology or reduced DLCO 1
  • Clinical suspicion for hypersensitivity pneumonitis, organizing pneumonia, or other specific ILD patterns 1
• Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is not indicated for the small mediastinal nodes (<1 cm) in this context, as reactive lymphadenopathy is expected with bronchiectasis 2, 4

Follow-Up Imaging

• Repeat CT chest in 3-6 months to assess for progression of interstitial changes or bronchiectasis 1
• Progressive fibrotic abnormality on serial CT would meet criteria for ILD diagnosis and warrant more aggressive evaluation 1

Management Strategy

Bronchiectasis-Specific Management

• Initiate airway clearance techniques if bronchiectasis is confirmed 1
• Consider inhaled bronchodilators if obstructive physiology is present 1
• Treat acute exacerbations with appropriate antibiotics based on sputum culture results 1

Monitoring for ILD Progression

• Serial PFTs every 3-6 months to detect physiologic decline (≥10% decline in FVC or ≥15% decline in DLCO suggests progressive disease) 1
• If progression is documented, referral to ILD specialist for consideration of antifibrotic therapy 1

Important Clinical Caveats

Pitfall: Dismissing CT Findings Based on Normal Chest X-Ray

• A normal chest radiograph has only 64% negative predictive value for excluding pulmonary causes of chronic cough 5
• CT scan is essential and has already revealed clinically significant findings (bronchiectasis in 11.9% and mediastinal lymphadenopathy in 8.5% of chronic cough patients with normal CXR) 5

Pitfall: Attributing Lymphadenopathy to Malignancy

• Mediastinal lymph nodes up to 0.8 cm are within normal limits and commonly reactive in bronchiectasis 2
• Nodes up to 20-30 mm can occur in chronic inflammatory lung diseases without malignancy 6
• No tissue diagnosis is needed for these small nodes in the absence of other concerning features 2, 4

Pitfall: Overlooking Early ILD

• The combination of interstitial changes and traction bronchiolectasis, even when subtle, warrants close monitoring as it may represent early fibrotic ILD 1
• Failure to follow up with serial imaging and PFTs may miss progressive disease that could benefit from early antifibrotic intervention 1